LONDON, June 7 Royalty Pharma: * Royalty Pharma increases offer to acquire Elan * Increased offer, including CVR, potentially values Elan share at up to $15.50
if three CVR payment events occur * Offering upfront cash value of $4.9 billion for Tysabri royalty * Urges Elan stockholders to vote " against all" items on the agenda at the
Elan EGM * Will waive down acceptance threshold to 50% plus one share if all other
conditions to increased offer satisfied * Offer to lapse if theravance resolution or any of the other resolutions
approved by Elan investors at Elan EGM * Source text for Eikon:
Legislation to fund US gov't through April clears procedural hurdle in Senate
WASHINGTON, Dec 9 A bill to fund the U.S. government cleared a procedural hurdle in the U.S. Senate on Friday and appeared poised to pass the chamber, averting a government shutdown.
UPDATE 2-Exxon CEO is now Trump's secretary of state favorite -transition official
GRAND RAPIDS, Mich., Dec 9 Exxon Mobil Corp Chief Executive Officer Rex Tillerson emerged on Friday as President-elect Donald Trump's leading candidate for U.S. secretary of state, a senior transition official said.